NCT05396131View on ClinicalTrials.gov

The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves.

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

January 7, 2022

Study Completion Date

January 7, 2022

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

Lung Sealant

The Aeriseal System uses a polymer foam to block or seal fissures, peripheral airways, alveoli, and collateral channels to achieve lung volume reduction.

DEVICE

Endobronchial Valve (EBV)

The Zephyr EBV System are one way valves inserted into the airways to reduce lung hyperinflation.

Trial Locations (1)

2109

Macquarie University, Macquarie Park

All Listed Sponsors
lead

Macquarie University, Australia

OTHER

NCT05396131 - The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves. | Biotech Hunter | Biotech Hunter